科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Journal of neuroinflammation2026-07-25

IFN-γ protects the human blood-brain barrier from Toxoplasma gondii-mediated dysfunction via CCL2 suppression.

Mia C Somenzi, Kameron T Bell, Abigail M Bitters, Collin S Stratton, Samantha R Springston, Kamryn E Zadeii, Rylee J Anderson, Avery V Stanley, Daisy Woellner-Santos, Scott G Canfield, Américo H López-Yglesias

原始摘要(英文原文)· Original abstract
The obligate intracellular parasite Toxoplasma gondii infects nearly one-third of the global population, yet its impact on human blood-brain barrier (BBB) function remains poorly defined. In this study, we use human induced pluripotent stem cell-derived (iPSC) brain-like microvascular endothelial cells (BMECs), a physiologically relevant BBB model, to investigate if T. gondii infection directly compromises barrier integrity. We show that infection induces robust monocyte chemotactic protein-1 (also known as CCL2) secretion from BMECs, and that CCL2 itself serves as a previously unrecognized driver of BBB dysfunction. Notably, interferon-gamma (IFN-γ) limits BMEC-derived CCL2 release and protects against parasite-mediated barrier damage. These findings identify an IFN-γ-dependent, BMEC-intrinsic defense mechanism that helps preserve central nervous system (CNS) integrity during infection. Collectively, this work establishes a mechanistic foundation for understanding how T. gondii disrupts the human BBB and reveals a novel protective role for IFN-γ in mitigating CNS barrier dysfunction.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

IFN-γ protects the human blood-brain barrier from Toxoplasma gondii-mediated dysfunction via CCL2 suppression. — 科研速览 Science Skim